HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazunori Kataoka Selected Research

cyclic arginine-glycine-aspartic acid peptide

10/2017cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
7/2017Multilayered polyion complexes with dissolvable silica layer covered by controlling densities of cRGD-conjugated PEG chains for cancer-targeted siRNA delivery.
12/2016Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
12/2015cRGD-installed polymeric micelles loading platinum anticancer drugs enable cooperative treatment against lymph node metastasis.
6/2015Density-tunable conjugation of cyclic RGD ligands with polyion complex vesicles for the neovascular imaging of orthotopic glioblastomas.
9/2014Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors.
3/2014Targeted gene delivery by polyplex micelles with crowded PEG palisade and cRGD moiety for systemic treatment of pancreatic tumors.
10/2013Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier.
6/2012Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection.
9/2007Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazunori Kataoka Research Topics

Disease

146Neoplasms (Cancer)
01/2022 - 01/2003
21Neoplasm Metastasis (Metastasis)
02/2021 - 03/2003
16Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 12/2009
9Breast Neoplasms (Breast Cancer)
02/2021 - 11/2011
8Glioblastoma (Glioblastoma Multiforme)
11/2021 - 10/2013
7Adenocarcinoma
01/2021 - 02/2007
6Colonic Neoplasms (Colon Cancer)
10/2017 - 01/2005
6Hepatocellular Carcinoma (Hepatoma)
07/2015 - 02/2005
5Hypoxia (Hypoxemia)
02/2021 - 07/2008
5Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2016 - 09/2014
4Triple Negative Breast Neoplasms
02/2021 - 12/2018
4Inflammation (Inflammations)
06/2019 - 06/2012
4Lung Neoplasms (Lung Cancer)
11/2017 - 02/2014
4Carcinoma (Carcinomatosis)
06/2016 - 01/2014
3Prostatic Neoplasms (Prostate Cancer)
11/2019 - 02/2016
3Squamous Cell Carcinoma of Head and Neck
10/2019 - 03/2013
3Spinal Cord Injuries (Spinal Cord Injury)
09/2019 - 01/2015
3Fibrosis (Cirrhosis)
06/2019 - 02/2007
3Melanoma (Melanoma, Malignant)
05/2015 - 10/2013
3Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 01/2014
3Pain (Aches)
01/2014 - 07/2012
3Hyperalgesia
01/2014 - 07/2012
3Corneal Neovascularization
12/2011 - 11/2005
2Brain Neoplasms (Brain Tumor)
01/2022 - 10/2013
2Glioma (Gliomas)
10/2021 - 12/2016
2Ischemia
01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

87MicellesIBA
10/2021 - 12/2003
37Pharmaceutical PreparationsIBA
10/2021 - 12/2003
26Small Interfering RNA (siRNA)IBA
01/2021 - 02/2005
18Messenger RNA (mRNA)IBA
01/2021 - 04/2010
17LigandsIBA
12/2020 - 07/2007
16PolymersIBA
12/2021 - 09/2003
15Ethylene Glycol (Monoethylene Glycol)IBA
11/2021 - 12/2003
14PlatinumIBA
08/2020 - 01/2005
12Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2008
12Peptides (Polypeptides)IBA
11/2017 - 09/2007
111-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2016 - 01/2003
10Cisplatin (Platino)FDA LinkGeneric
01/2022 - 12/2003
10cyclic arginine-glycine-aspartic acid peptideIBA
10/2017 - 09/2007
10DNA (Deoxyribonucleic Acid)IBA
01/2017 - 12/2008
8Contrast MediaIBA
01/2017 - 04/2007
7Therapeutic UsesIBA
01/2022 - 09/2007
7AcidsIBA
08/2020 - 02/2005
7Glucose (Dextrose)FDA LinkGeneric
01/2020 - 09/2003
7calcium phosphateIBA
07/2017 - 08/2012
6IntegrinsIBA
11/2017 - 03/2003
6DisulfidesIBA
01/2017 - 04/2010
6Photosensitizing Agents (Photosensitizers)IBA
05/2016 - 12/2003
6Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014 - 01/2005
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 07/2008
5Epirubicin (Ellence)FDA LinkGeneric
10/2020 - 01/2016
5Lysine (L-Lysine)FDA Link
11/2019 - 02/2005
5GoldIBA
10/2019 - 09/2010
5Drug CarriersIBA
07/2016 - 01/2005
5Gadolinium DTPA (Magnevist)FDA Link
04/2016 - 01/2013
5GadoliniumIBA
04/2016 - 09/2010
5PAsp(DET)IBA
01/2016 - 12/2008
5LuciferasesIBA
01/2016 - 04/2005
4Biological ProductsIBA
01/2022 - 01/2005
4Long Noncoding RNAIBA
01/2021 - 12/2016
4AntigensIBA
12/2020 - 07/2013
4N-Acetylneuraminic Acid (Sialic Acid)IBA
08/2020 - 09/2009
4Transcription Factors (Transcription Factor)IBA
06/2019 - 01/2008
4Angiogenic ProteinsIBA
01/2017 - 01/2011
44-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA
03/2016 - 12/2008
4polyethylene glycol-block-polyaspartic acidIBA
06/2012 - 12/2003
3Immune Checkpoint InhibitorsIBA
11/2021 - 01/2020
3Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
11/2021 - 10/2019
3liposomal doxorubicin (Doxil)FDA Link
02/2021 - 05/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 11/2011
3Polo-Like Kinase 1IBA
10/2019 - 02/2014
3IronIBA
01/2019 - 04/2007
3ProdrugsIBA
01/2019 - 01/2016
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2017 - 09/2005
3Glutamic Acid (Glutamate)FDA Link
01/2017 - 12/2003
3CholesterolIBA
03/2016 - 09/2014
3Liposomes (Liposome)IBA
02/2016 - 12/2006
3EnzymesIBA
01/2016 - 12/2008
3ferric oxide (iron oxide)IBA
06/2015 - 09/2010
3MetalsIBA
01/2013 - 12/2003
3DEET (DET)IBA
06/2012 - 07/2009
3Transforming Growth Factor beta (TGF-beta)IBA
12/2009 - 02/2007
3Dendrimers (Dendrons)IBA
02/2009 - 12/2003
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2009 - 02/2007
2Matrix Metalloproteinases (MMPs)IBA
12/2021 - 03/2003
2AntibodiesIBA
11/2021 - 01/2020
2tranilastIBA
02/2021 - 01/2020
2HydrazonesIBA
01/2021 - 09/2005
2Amino AcidsFDA Link
01/2021 - 08/2013
2StaurosporineIBA
10/2020 - 10/2017
2benzeneboronic acidIBA
08/2020 - 10/2013

Therapy/Procedure

60Therapeutics
01/2022 - 12/2003
9Drug Therapy (Chemotherapy)
01/2021 - 03/2013
9Photochemotherapy (Photodynamic Therapy)
05/2016 - 01/2003
8Lasers (Laser)
10/2021 - 03/2008
7Intravenous Injections
01/2021 - 09/2010
6Immunotherapy
01/2022 - 01/2017
3Radiotherapy
01/2021 - 01/2015
3Intravenous Administration
12/2020 - 05/2017
3Neutron Capture Therapy
04/2016 - 06/2015